12/4
09:30 am
mrk
HSBC upgrades Merck stock to Buy on 2025 opportunities [Yahoo! Finance]
Low
Report
HSBC upgrades Merck stock to Buy on 2025 opportunities [Yahoo! Finance]
12/4
08:11 am
mrk
Merck & Co., Inc. (NYSE: MRK) was upgraded by analysts at HSBC Holdings plc from a "hold" rating to a "buy" rating. They now have a $130.00 price target on the stock.
Low
Report
Merck & Co., Inc. (NYSE: MRK) was upgraded by analysts at HSBC Holdings plc from a "hold" rating to a "buy" rating. They now have a $130.00 price target on the stock.
12/4
07:15 am
mrk
Beam Therapeutics Expands its Board of Directors with Appointment of Chirfi Guindo, Global Biopharma Strategy and Commercial Leader [Yahoo! Finance]
Low
Report
Beam Therapeutics Expands its Board of Directors with Appointment of Chirfi Guindo, Global Biopharma Strategy and Commercial Leader [Yahoo! Finance]
12/4
02:06 am
mrk
TME Pharma Announces Corporate Strategy Update and Upcoming €2.6 Million Guaranteed Financing With Intention to Launch Public Offer Open Only to Shareholders to Enable Completion of Transactions Around NOX-A12 and NOX-E36 by June 2025 [Yahoo! Finance]
Low
Report
TME Pharma Announces Corporate Strategy Update and Upcoming €2.6 Million Guaranteed Financing With Intention to Launch Public Offer Open Only to Shareholders to Enable Completion of Transactions Around NOX-A12 and NOX-E36 by June 2025 [Yahoo! Finance]
12/3
03:27 pm
mrk
Merck Receives FDA Breakthrough Therapy Designation for Investigational Lung Cancer Treatment [Yahoo! Finance]
Low
Report
Merck Receives FDA Breakthrough Therapy Designation for Investigational Lung Cancer Treatment [Yahoo! Finance]
12/3
06:57 am
mrk
FDA Grants Breakthrough Therapy Designation to Sacituzumab Tirumotecan (sac-TMT) for the Treatment of Certain Patients With Previously Treated Advanced or Metastatic Nonsquamous Non-Small Cell Lung Cancer With EGFR Mutations [Yahoo! Finance]
Low
Report
FDA Grants Breakthrough Therapy Designation to Sacituzumab Tirumotecan (sac-TMT) for the Treatment of Certain Patients With Previously Treated Advanced or Metastatic Nonsquamous Non-Small Cell Lung Cancer With EGFR Mutations [Yahoo! Finance]
12/3
06:45 am
mrk
FDA Grants Breakthrough Therapy Designation to Sacituzumab Tirumotecan (sac-TMT) for the Treatment of Certain Patients With Previously Treated Advanced or Metastatic Nonsquamous Non-Small Cell Lung Cancer With EGFR Mutations
Low
Report
FDA Grants Breakthrough Therapy Designation to Sacituzumab Tirumotecan (sac-TMT) for the Treatment of Certain Patients With Previously Treated Advanced or Metastatic Nonsquamous Non-Small Cell Lung Cancer With EGFR Mutations
12/2
06:35 am
mrk
Nasal Corticosteroids Market to Reach Over $11.4 Billion by 2034 Amid Rising Chronic Respiratory Disorders | Transparency Market Research, Inc. [Yahoo! Finance]
Low
Report
Nasal Corticosteroids Market to Reach Over $11.4 Billion by 2034 Amid Rising Chronic Respiratory Disorders | Transparency Market Research, Inc. [Yahoo! Finance]
11/28
04:14 am
mrk
The Smartest Dividend Stocks to Buy With $3,000 Right Now [Yahoo! Finance]
Low
Report
The Smartest Dividend Stocks to Buy With $3,000 Right Now [Yahoo! Finance]
11/27
01:37 am
mrk
Kelun-Biotech's TROP2 ADC Sacituzumab tirumotecan (sac-TMT) Approved For Marketing By NMPA Of China For 2L+ Advanced or Metastatic TNBC [Yahoo! Finance]
Low
Report
Kelun-Biotech's TROP2 ADC Sacituzumab tirumotecan (sac-TMT) Approved For Marketing By NMPA Of China For 2L+ Advanced or Metastatic TNBC [Yahoo! Finance]
11/27
01:32 am
mrk
Kelun-Biotech's TROP2 ADC Sacituzumab tirumotecan (sac-TMT) Approved For Marketing By NMPA Of China For 2L+ Advanced or Metastatic TNBC [Yahoo! Finance]
Low
Report
Kelun-Biotech's TROP2 ADC Sacituzumab tirumotecan (sac-TMT) Approved For Marketing By NMPA Of China For 2L+ Advanced or Metastatic TNBC [Yahoo! Finance]
11/26
04:58 pm
mrk
Merck Stock Up as Winrevair Meets Goal in Advanced PAH Study [Yahoo! Finance]
Low
Report
Merck Stock Up as Winrevair Meets Goal in Advanced PAH Study [Yahoo! Finance]
11/26
06:50 am
mrk
Moderna's Shares Surge Amid Promising Vaccine Developments and Strategic Partnerships [Yahoo! Finance]
Low
Report
Moderna's Shares Surge Amid Promising Vaccine Developments and Strategic Partnerships [Yahoo! Finance]
11/26
06:50 am
mrk
Merck to Participate in the Citi 2024 Global Healthcare Conference [Yahoo! Finance]
Low
Report
Merck to Participate in the Citi 2024 Global Healthcare Conference [Yahoo! Finance]
11/26
06:45 am
mrk
Merck to Participate in the Citi 2024 Global Healthcare Conference
Low
Report
Merck to Participate in the Citi 2024 Global Healthcare Conference
11/25
11:01 am
mrk
Glioblastoma Multiforme Treatment Market Size to Reach USD 5.68 Bn by 2033 [Yahoo! Finance]
Low
Report
Glioblastoma Multiforme Treatment Market Size to Reach USD 5.68 Bn by 2033 [Yahoo! Finance]
11/25
06:51 am
mrk
Merck Announces Pivotal Phase 3 ZENITH Trial Evaluating WINREVAIR™ (sotatercept-csrk) Met Primary Endpoint at Interim Analysis [Yahoo! Finance]
Low
Report
Merck Announces Pivotal Phase 3 ZENITH Trial Evaluating WINREVAIR™ (sotatercept-csrk) Met Primary Endpoint at Interim Analysis [Yahoo! Finance]
11/25
06:45 am
mrk
Merck Announces Pivotal Phase 3 ZENITH Trial Evaluating WINREVAIR™ (sotatercept-csrk) Met Primary Endpoint at Interim Analysis
Low
Report
Merck Announces Pivotal Phase 3 ZENITH Trial Evaluating WINREVAIR™ (sotatercept-csrk) Met Primary Endpoint at Interim Analysis
11/25
04:37 am
mrk
Merck & Co., Inc. (MRK): Among the Most Promising Cancer Stocks According to Hedge Funds [Yahoo! Finance]
Low
Report
Merck & Co., Inc. (MRK): Among the Most Promising Cancer Stocks According to Hedge Funds [Yahoo! Finance]
11/24
08:36 pm
mrk
Hanmi Pharmaceutical and Beijing Hanmi Progress Clinical Trials of Co-developed BH3120 as a Next-Generation Cancer Immunotherapy [Yahoo! Finance]
Low
Report
Hanmi Pharmaceutical and Beijing Hanmi Progress Clinical Trials of Co-developed BH3120 as a Next-Generation Cancer Immunotherapy [Yahoo! Finance]
11/24
07:18 pm
mrk
Popular asthma drug Singulair could be linked to mental health side effects, suicides: FDA [USA TODAY]
Low
Report
Popular asthma drug Singulair could be linked to mental health side effects, suicides: FDA [USA TODAY]
11/22
04:20 pm
mrk
Merck Recommends Rejection of TRC Capital's "Mini-Tender" Offer [Yahoo! Finance]
Low
Report
Merck Recommends Rejection of TRC Capital's "Mini-Tender" Offer [Yahoo! Finance]
11/22
04:17 pm
mrk
Merck Recommends Rejection of TRC Capital’s “Mini-Tender” Offer
Low
Report
Merck Recommends Rejection of TRC Capital’s “Mini-Tender” Offer
11/22
07:16 am
mrk
Merck to Participate in the 7th Annual Evercore ISI HealthCONx Conference [Yahoo! Finance]
Low
Report
Merck to Participate in the 7th Annual Evercore ISI HealthCONx Conference [Yahoo! Finance]
11/22
07:15 am
mrk
Merck to Participate in the 7th Annual Evercore ISI HealthCONx Conference
Low
Report
Merck to Participate in the 7th Annual Evercore ISI HealthCONx Conference